annual FCF:
-$69.31M-$44.37M(-177.92%)Summary
- As of today (July 11, 2025), SLNO annual free cash flow is -$69.31 million, with the most recent change of -$44.37 million (-177.92%) on December 31, 2024.
- During the last 3 years, SLNO annual FCF has fallen by -$41.52 million (-149.40%).
- SLNO annual FCF is now -7718.84% below its all-time high of -$886.50 thousand, reached on December 31, 2013.
Performance
SLNO Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$32.76M-$8.76M(-36.49%)Summary
- As of today (July 11, 2025), SLNO quarterly free cash flow is -$32.76 million, with the most recent change of -$8.76 million (-36.49%) on March 31, 2025.
- Over the past year, SLNO quarterly FCF has dropped by -$20.22 million (-161.24%).
- SLNO quarterly FCF is now -1672.13% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$89.53M-$20.22M(-29.17%)Summary
- As of today (July 11, 2025), SLNO TTM free cash flow is -$89.53 million, with the most recent change of -$20.22 million (-29.17%) on March 31, 2025.
- Over the past year, SLNO TTM FCF has dropped by -$58.78 million (-191.15%).
- SLNO TTM FCF is now -4396.99% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
SLNO Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -177.9% | -161.2% | -191.2% |
| 3 y3 years | -149.4% | -414.9% | -235.8% |
| 5 y5 years | -298.4% | -478.9% | -307.1% |
SLNO Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -233.3% | at low | -608.0% | at low | -330.6% | at low |
| 5 y | 5-year | -298.4% | at low | -608.0% | at low | -330.6% | at low |
| alltime | all time | -7718.8% | at low | -1672.1% | at low | -4397.0% | at low |
SLNO Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$32.76M(+36.5%) | -$89.53M(+29.2%) |
| Dec 2024 | -$69.31M(+177.9%) | -$24.00M(+58.8%) | -$69.31M(+34.3%) |
| Sep 2024 | - | -$15.12M(-14.4%) | -$51.63M(+20.5%) |
| Jun 2024 | - | -$17.66M(+40.8%) | -$42.84M(+39.3%) |
| Mar 2024 | - | -$12.54M(+98.6%) | -$30.75M(+23.3%) |
| Dec 2023 | -$24.94M(+19.9%) | -$6.31M(-0.3%) | -$24.94M(+4.9%) |
| Sep 2023 | - | -$6.33M(+13.8%) | -$23.77M(+7.6%) |
| Jun 2023 | - | -$5.57M(-17.3%) | -$22.10M(+4.4%) |
| Mar 2023 | - | -$6.73M(+30.7%) | -$21.16M(+1.8%) |
| Dec 2022 | -$20.79M(-25.2%) | -$5.15M(+10.6%) | -$20.79M(-7.7%) |
| Sep 2022 | - | -$4.66M(+0.6%) | -$22.52M(-3.2%) |
| Jun 2022 | - | -$4.63M(-27.3%) | -$23.28M(-12.7%) |
| Mar 2022 | - | -$6.36M(-7.5%) | -$26.66M(-4.1%) |
| Dec 2021 | -$27.79M(+10.2%) | -$6.88M(+27.1%) | -$27.79M(+0.0%) |
| Sep 2021 | - | -$5.41M(-32.5%) | -$27.79M(-2.6%) |
| Jun 2021 | - | -$8.01M(+7.0%) | -$28.54M(+5.5%) |
| Mar 2021 | - | -$7.49M(+9.0%) | -$27.06M(+7.3%) |
| Dec 2020 | -$25.23M(+45.0%) | -$6.87M(+11.4%) | -$25.23M(+7.6%) |
| Sep 2020 | - | -$6.17M(-5.6%) | -$23.44M(+6.6%) |
| Jun 2020 | - | -$6.53M(+15.5%) | -$21.99M(+13.6%) |
| Mar 2020 | - | -$5.66M(+11.4%) | -$19.36M(+11.3%) |
| Dec 2019 | -$17.40M(+48.8%) | -$5.08M(+7.7%) | -$17.40M(+8.4%) |
| Sep 2019 | - | -$4.72M(+21.0%) | -$16.05M(+14.5%) |
| Jun 2019 | - | -$3.90M(+5.5%) | -$14.02M(+8.9%) |
| Mar 2019 | - | -$3.70M(-1.1%) | -$12.87M(+10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$11.69M(+17.5%) | -$3.74M(+39.4%) | -$11.69M(+9.4%) |
| Sep 2018 | - | -$2.68M(-2.5%) | -$10.68M(+6.4%) |
| Jun 2018 | - | -$2.75M(+9.2%) | -$10.04M(-2.4%) |
| Mar 2018 | - | -$2.52M(-7.7%) | -$10.29M(+3.4%) |
| Dec 2017 | -$9.95M(-26.4%) | -$2.73M(+33.6%) | -$9.95M(+0.5%) |
| Sep 2017 | - | -$2.04M(-31.8%) | -$9.90M(-7.0%) |
| Jun 2017 | - | -$3.00M(+37.2%) | -$10.65M(-8.9%) |
| Mar 2017 | - | -$2.18M(-18.6%) | -$11.69M(-13.5%) |
| Dec 2016 | -$13.51M(+27.4%) | -$2.68M(-3.8%) | -$13.51M(-5.6%) |
| Sep 2016 | - | -$2.79M(-31.0%) | -$14.32M(-1.7%) |
| Jun 2016 | - | -$4.04M(+0.9%) | -$14.57M(+13.9%) |
| Mar 2016 | - | -$4.00M(+14.8%) | -$12.80M(+20.7%) |
| Dec 2015 | -$10.61M(+134.9%) | -$3.49M(+14.6%) | -$10.61M(+21.8%) |
| Sep 2015 | - | -$3.04M(+34.3%) | -$8.71M(+25.8%) |
| Jun 2015 | - | -$2.27M(+25.2%) | -$6.92M(+19.0%) |
| Mar 2015 | - | -$1.81M(+14.1%) | -$5.82M(+28.8%) |
| Dec 2014 | -$4.51M(+409.3%) | -$1.59M(+26.2%) | -$4.51M(+23.7%) |
| Sep 2014 | - | -$1.26M(+8.4%) | -$3.65M(+10.0%) |
| Jun 2014 | - | -$1.16M(+128.1%) | -$3.32M(-4.6%) |
| Mar 2014 | - | -$509.00K(-29.6%) | -$3.48M(+292.5%) |
| Dec 2013 | -$886.50K(-74.7%) | -$722.50K(-21.9%) | -$886.50K(+440.5%) |
| Sep 2013 | - | -$925.10K(-30.0%) | -$164.00K(-121.5%) |
| Jun 2013 | - | -$1.32M(-163.5%) | $761.10K(-63.5%) |
| Mar 2013 | - | $2.08M | $2.08M |
| Dec 2012 | -$3.50M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual FCF year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Soleno Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM FCF year-on-year change?
What is Soleno Therapeutics, Inc. annual free cash flow?
The current annual FCF of SLNO is -$69.31M
What is the all time high annual FCF for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual free cash flow is -$886.50K
What is Soleno Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, SLNO annual free cash flow has changed by -$44.37M (-177.92%)
What is Soleno Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of SLNO is -$32.76M
What is the all time high quarterly FCF for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly free cash flow is $2.08M
What is Soleno Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, SLNO quarterly free cash flow has changed by -$20.22M (-161.24%)
What is Soleno Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of SLNO is -$89.53M
What is the all time high TTM FCF for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM free cash flow is $2.08M
What is Soleno Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, SLNO TTM free cash flow has changed by -$58.78M (-191.15%)